MaxCyte, Inc. (MXCT)

MaxCyte Revenue

In the year 2025, MaxCyte had annual revenue of $33.03M, down -14.50%. MaxCyte had revenue of $7.30M in the quarter ending December 31, 2025, a decrease of -16.02%.

• Revenue (ttm): $33.03M
• Revenue Growth: -14.50%
• P/S Ratio: 2.74
• Revenue / Employee: $362,923
• Employees: 91
• Market Cap: 90.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	33.03M	-5.60M	-14.50%
Dec 31, 2024	38.63M	-2.66M	-6.44%
Dec 31, 2023	41.29M	-2.97M	-6.72%
Dec 31, 2022	44.26M	10.37M	30.59%
Dec 31, 2021	33.89M	7.73M	29.52%
Dec 31, 2020	26.17M	4.55M	21.04%
Dec 31, 2019	21.62M	-	-